SCHEMBL7984655

SCHEMBL7984655

Nc1cccc(-c2nc3ncn(Cc4ccccc4)c3c(=O)[nH]2)c1

nearest known ligand 0.53

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.53
ALDH1A1 P00352 3/20 0.53
KMT2A Q03164 1/20 0.53
HPGD P15428 2/20 0.51
PNP P00491 2/20 0.46
GAA P10253 1/20 0.43
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
TP53 P04637 1/20 0.41
RAB9A P51151 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PARN O95453 1/20 0.41
CNOT7 Q9UIV1 1/20 0.41
PRMT1 Q99873 1/20 0.41
BRD4 O60885 1/20 0.41
ADORA3 P0DMS8 1/20 0.41
ADORA2A P29274 1/20 0.41
TYMS P04818 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL7987658 0.99 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7991564 0.92 SMN1; SMN2 (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7974420 0.90 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7988580 0.90 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7984419 0.90 SMN1; SMN2 (0.44) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7975265 0.90 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7985297 0.89 ALDH1A1 (0.43) SMN1; SMN2ALDH1A1KMT2AHPGD
SCHEMBL7991556 0.89 HPGD (0.43) SMN1; SMN2ALDH1A1KMT2AHPGDKDM4E
SCHEMBL7974010 0.89 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDPNP
SCHEMBL7986351 0.89 KDM4E (0.50) SMN1; SMN2ALDH1A1KMT2AHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed